Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 249-258

  Moreno, S ^a,j   Garcia Samaniego J ^b   Moreno, A ^a   Ortega, E ^c   Pineda, J A ^d   Del Romero, J ^e   Tural, C ^f   Von Wichmann, M A ^g   Berenguer, J ^h   Castro, A ⁱ   Espacio, R ^e  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e Fundación Para la Formación e Información Sobre Tratamientos en El VIH SIDA   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g HOSPITAL DONOSTIA   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁱ HOSPITAL JUAN CANALEJO   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

more..

Author keywords

Elastometry; HIV HCV co infection; Liver biopsy; Liver fibrosis; Serum markers

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 2 MACROGLOBULIN; ANALGESIC AGENT; ANTIFIBROTIC AGENT; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HYALURONIC ACID; LAMININ; METALLOPROTEINASE; OPIATE; PEGINTERFERON; PROTHROMBIN; RIBAVIRIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ASSAY; BILIARY PERITONITIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ELASTOGRAPHY; HEMOBILIA; HEMOPERITONEUM; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MIXED INFECTION; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT;

BIOLOGICAL MARKERS; ELASTICITY IMAGING TECHNIQUES; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 61449097678     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01088.x     Document Type: Review

References (54)

1. Bica I, McGovern B, Dhar R et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001 32 : 492 497.
2. Camino X, Iribarren JA, Arrizabalaga J, Rodríguez F, Von Wichmann AM. Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy. Enferm Infecc Microbiol Clin 2001 19 : 85 86.
3. Soriano V, García-Samaniego J, Bravo R et al. Morbilidad y mortalidad asociadas a hepatopatía crónica viral en pacientes infectados por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1995 104 : 641 644.
4. Soriano V, Miró JM, García-Samaniego J et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004 11 : 2 17.
5. González J Grupo de trabajo para la elaboración de recomendaciones sobre las hepatitis virales en pacientes infectados por el VIH. Coinfección por el VIH y virus de las hepatitis A, B y C en pacientes adultos. Revisión y recomendaciones de GESIDA/PNS. In : Terapia Antirretroviral y Enfermedades Asociadas al VIH (2000-2002). Documentos de Consenso de Gesida. Madrid : Doyma, 2002, pp. 173 225.
6. Carrat F, Bani-Sadr F, Pol S et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004 292 : 2839 2848.
7. Chung RT, Andersen J, Volberding P et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004 351 : 451 459.
8. Laguno M, Murillas J, Blanco JL et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 2004 18 : F27 F36.
9. Torriani FJ, Rodriguez-Torres M, Rockstroh JK et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004 351 : 438 450.
10. Cadranel J, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000 32 : 477 481.
11. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457.
12. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 2618.
13. Saito H, Tada S, Nakamoto N et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 2004 29 : 97 103.
14. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 128 : 343 350.
15. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001 344 : 495 500.
16. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002 36 (5 Suppl. 1 S152 S160.
17. Colloredo G, Guido M, Sonzogni A et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003 39 : 239 244.
18. Ghany MG, Kleiner DE, Alter H et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003 124 : 97 104.
19. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003 38 (Suppl. 1 S38 S53.
20. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 36 (4 Pt 1 986 992.
21. Macias J, Girón González JA, González Serrano M et al. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006 55 : 409 414.
22. Cacoub B, Carrat F, Bédossa P et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV coinfected patients: the fibrovic study-ANRS HC02. J Hepatol 2008 48 : 765 773.
23. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001 357 : 1069 1075.
24. Rossi E, Adams L, Prins A et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003 49 : 450 454.
25. Myers RP, Benhamou Y, Imbert-Bismut F et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003 17 : 721 725.
26. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526.
27. Kelleher TB, Mehta SH, Bhaskar R et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 2005 43 : 78 84.
28. Nunes D, Fleming C, Offner G et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 2005 40 : 538 544.
29. Al-Mohri H, Cooper C, Murphy T, Klein MB. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med 2005 6 : 375 378.
30. Shastry L, Wilson T, Lascher S, Nord JA. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients. AIDS 2007 21 : 2541 2543.
31. Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta 2008 397 : 51 54.
32. Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int 2008 28 : 486 493.
33. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 : 1317 1325.
34. Berenguer J, Bellón JM, Miralles P et al. Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data. J Viral Hepatitis 2007 14 : 859 869.
35. Patel K, Gordon SC, Jacobson I et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004 41 : 935 942.
36. Rosenberg WM, Voelker M, Thiel R et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004 127 : 1704 1713.
37. Adams LA, Bulsara M, Rossi E et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005 51 : 1867 1873.
38. Mendoza J, Gómez Domínguez E, Moreno-Otero R. Elastografía de transición (Fibroscan), un nuevo método no invasivo en la valoración de la fibrosis hepática. Med Clin (Barc) 2006 126 : 220 221.
39. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 55 : 403 408.
40. Shaheen AAM, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007 102 : 2589 2600.
41. Vergara S, Macias J, Rivero A et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and Hepatitis C virus coinfection. Clin Infect Dis 2007 45 : 969 974.
42. Nelson M, Matthews G, Brook MG, Main J, BHIVA Coinfection Guideline Committee. British HIV Association. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005). HIV Med 2005 6 (Suppl. 2 96 106.
43. Rockstroh J, Bhagani S, Bruno R et al. Guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults, 2007. Available at: http://www.eacs.eu/guide/3-Treatment- chronic-hepatitis-coinfection.pdf.
44. Valle J, Macias J, Barreiro P et al. Improving the differentiation of mild from significant liver fibrosis in HIV/HCV-co-infected patients using transient elastometry. 15th Conference on Retroviruses and Opportunistic Infections, Boston, USA, 2008 (Abstract 1053).
45. Kettaneh A, Marcellin P, Douvin C et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007 46 : 628 634.
46. Foucher J, Castéra L, Bernard PH et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006 18 : 411 412.
47. Vispo E, Maida I, de Lendinghen V et al. Influence of inflammatory activity in the liver biopsy on fibrosis values reported by fibroscan in patients with chronic hepatitis C. 3rd International Workshop on HIV and Hepatitis Co-Infection, Paris, France, 2007 (Abstract 63).
48. Ganne-Carrié N, Ziol M, de Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006 44 : 1511 1517.
49. Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007 45 : 1290 1297.
50. Kazemi F, Kettaneh A, N'kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006 45 : 230 235.
51. Recio-Sánchez E, Macías J, Merchante N et al. Usefulness of liver stiffness to predict esophageal varices requiring therapy in HIV/HCV co-infected patients with cirrhosis. 4th International HIV and Hepatitis Co-infection Workshop, Madrid, Spain, 2008 (Abstract: 20).
52. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006 239 : 425 437.
53. Aubé C, Racineaux PX, Lebigot J et al. Diagnostic et quantification de la fibrose hépatique par RM de difusión résultats préliminaires. J Radiol 2004 85 : 301 306.
54. Romero-Gómez M, Gómez-González E, Madrazo A et al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology 2008 47 : 810 816.